Yoichiro Tohi

548 total citations
63 papers, 246 citations indexed

About

Yoichiro Tohi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yoichiro Tohi has authored 63 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 13 papers in Oncology. Recurrent topics in Yoichiro Tohi's work include Prostate Cancer Diagnosis and Treatment (27 papers), Prostate Cancer Treatment and Research (20 papers) and Bladder and Urothelial Cancer Treatments (18 papers). Yoichiro Tohi is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (27 papers), Prostate Cancer Treatment and Research (20 papers) and Bladder and Urothelial Cancer Treatments (18 papers). Yoichiro Tohi collaborates with scholars based in Japan, United States and Netherlands. Yoichiro Tohi's co-authors include Mikio Sugimoto, Takuma Kato, Rikiya Taoka, Yuki Matsuoka, Hiroyuki Tsunemori, Nobufumi Ueda, Masashi Kubota, Mutsushi Kawakita, Issei Suzuki and Reiji Haba and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yoichiro Tohi

58 papers receiving 245 citations

Peers

Yoichiro Tohi

PRM

SURGE

ONCOL

UROLO

Sacit Nuri Görgel Türkiye

Pastora Beardo Spain

U. Witzsch Germany

I‐Hung Shao Taiwan

F Rodríguez-Rubio Spain

Riccardo Giovannone Italy

Ece Dilege Türkiye

Sachin Agrawal United Kingdom

Yuanhu Yuan China

Mayer B. Grob United States

Sacit Nuri Görgel Türkiye

Yoichiro Tohi

78 ×0.6

PRM

139 ×1.3

SURGE

75 ×1.7

ONCOL

90 ×2.6

UROLO

40 ×1.4

Citations per year, relative to Yoichiro Tohi Yoichiro Tohi (= 1×) peers Sacit Nuri Görgel

Countries citing papers authored by Yoichiro Tohi

Since Specialization

Citations

This map shows the geographic impact of Yoichiro Tohi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichiro Tohi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichiro Tohi more than expected).

Fields of papers citing papers by Yoichiro Tohi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoichiro Tohi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichiro Tohi. The network helps show where Yoichiro Tohi may publish in the future.

Co-authorship network of co-authors of Yoichiro Tohi

This figure shows the co-authorship network connecting the top 25 collaborators of Yoichiro Tohi. A scholar is included among the top collaborators of Yoichiro Tohi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoichiro Tohi. Yoichiro Tohi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukuhara, Hiroshi, et al.. (2026). Active surveillance for patients with prostate cancer aged ≥75 years: the Prostate Cancer Research International: Active Surveillance ( PRIAS) ‐ JAPAN study. British Journal of Urology. 137(4). 650–658.

Tohi, Yoichiro, Satoshi Harada, Yohei Abe, et al.. (2025). Shifts in Diagnostic Approaches for Prostate Cancer: Impact of MRI ‐Informed Biopsies on Low‐Risk Cancer Detection. International Journal of Urology. 32(11). 1622–1627. 2 indexed citations

Honda, Tomoko, Yoichiro Tohi, Yuki Matsuoka, et al.. (2025). A Case of Hemophagocytic Lymphohistiocytosis During Immune Checkpoint Inhibitor Treatment for Metastatic Renal Cell Carcinoma, Complicated by Pancytopenia Attributed to Cytomegalovirus Infection. IJU Case Reports. 8(4). 423–426. 1 indexed citations

Tohi, Yoichiro, Takuma Kato, Satoshi Harada, et al.. (2025). Overuse of imaging in prostate cancer staging. International Journal of Urology. 32(5). 533–539. 1 indexed citations

Blas, Leandro, Masaki Shiota, Takuma Kato, et al.. (2025). Active Surveillance in Prostate Cancer With Intermediate‐Risk Features: The PRIAS‐JAPAN Study. International Journal of Urology. 32(7). 823–827. 2 indexed citations

Kato, Takuma, Ryuji Matsumoto, Akira Yokomizo, et al.. (2024). Outcomes of active surveillance for Japanese patients with prostate cancer ( PRIAS ‐ JAPAN ). British Journal of Urology. 134(4). 652–658. 3 indexed citations

Abe, Yohei, Masashi Kubota, Yoichiro Tohi, et al.. (2024). Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer. International Journal of Urology. 31(10). 1102–1106. 1 indexed citations

Tohi, Yoichiro, Takuma Kato, Tomoko Honda, et al.. (2024). Impact of the coronavirus disease pandemic on robot‐assisted radical prostatectomy and urologists' treatment behaviors: A single tertiary center retrospective study. International Journal of Urology. 31(8). 899–905. 1 indexed citations

Tohi, Yoichiro, Takuma Kato, Tomoko Honda, et al.. (2024). Impact of frailty on cancer-related fatigue and quality of life in outpatients with prostate cancer: a cross-sectional study of patient-reported outcomes. Japanese Journal of Clinical Oncology. 54(6). 708–715. 1 indexed citations

10.

Kato, Takuma, Yoichiro Tohi, Tomoko Honda, et al.. (2023). A national questionnaire survey of Japanese urologists on treatment perspectives for elderly prostate cancer patients. International Journal of Urology. 30(8). 672–680. 2 indexed citations

11.

Taoka, Rikiya, Keisuke Yamada, Tomoko Honda, et al.. (2023). Oral 5-aminolevulinic acid administration before transurethral resection of bladder tumor induces perioperative nausea and vomiting. Photodiagnosis and Photodynamic Therapy. 43. 103707–103707. 5 indexed citations

12.

Honda, Tomoko, Yuki Matsuoka, Yoichiro Tohi, et al.. (2023). Usefulness of fluorescent ureteral catheter during laparoscopic residual ureterectomy. IJU Case Reports. 7(2). 120–122. 2 indexed citations

13.

Tohi, Yoichiro, Ryou Ishikawa, Takuma Kato, et al.. (2023). Increasing age predicts adverse pathology including intraductal carcinoma of the prostate and cribriform patterns in deferred radical prostatectomy after upfront active surveillance for Gleason grade group 1 prostate cancer: analysis of prospective observational study cohort. Japanese Journal of Clinical Oncology. 53(10). 984–990. 1 indexed citations

14.

Kubota, Masashi, Takashi Matsuoka, Issei Suzuki, et al.. (2022). Effect of continued perioperative antithrombotic therapy on bleeding outcomes following laparoscopic nephrectomy and nephroureterectomy. Asian Journal of Endoscopic Surgery. 16(1). 7–13. 1 indexed citations

15.

Kato, Takuma, Akira Yokomizo, Ryuji Matsumoto, et al.. (2022). Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS‐JAPAN study. International Journal of Urology. 29(11). 1271–1278. 5 indexed citations

16.

Kato, Takuma, Yoichiro Tohi, Tomoko Honda, et al.. (2022). A national questionnaire survey of Japanese urologists on active surveillance for low‐ and intermediate‐risk prostate cancer. International Journal of Urology. 30(3). 289–297. 2 indexed citations

17.

Taoka, Rikiya, Yuki Matsuoka, Tomoko Honda, et al.. (2022). Photodynamic diagnosis-assisted transurethral resection using oral 5-aminolevulinic acid decreases residual cancer and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer. Photodiagnosis and Photodynamic Therapy. 38. 102838–102838. 18 indexed citations

18.

Tohi, Yoichiro, Takuma Kato, Tomoko Honda, et al.. (2022). Active surveillance in younger patients with prostate cancer: clinical characteristics including longitudinal patient-reported outcomes. Japanese Journal of Clinical Oncology. 53(4). 335–342. 1 indexed citations

19.

Tohi, Yoichiro, et al.. (2022). Successful establishment of crowdfunding to develop new diagnostic tools for chronic prostatitis. International Journal of Urology. 29(6). 600–602. 1 indexed citations

20.

Kato, Takuma, Hiromi Hirama, Koji Mitsuzuka, et al.. (2021). Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN. Prostate Cancer and Prostatic Diseases. 25(4). 666–671. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact